ARThe article discusses the progress in treating hepatitis C in Argentina, noting that while effective treatments are available and covered by the healthcare system, the main challenge remains identifying individuals infected with the virus. According to Ministry of Health estimates, between 225,000 and 300,000 people live with chronic hepatitis C infection, but less than half have received a diagnosis, and fewer than 35,000 to 45,000 have started treatment. Only around 15% of those infected were treated, and less than 12% achieved cure, keeping the country below international elimination targets. Dr. Marcelo Silva, head of the Clinical Research Unit at the Austral University Hospital, highlights that the main barrier is the gap in detection, emphasizing the need for improved adherence to medical follow-up and re-engagement of patients who have been diagnosed but not treated. A regional study involving 45 hospitals in Latin America identified that 43.5% of patients had lost medical follow-up, citing reasons such as lack of coverage, relocation, seeking second opinions, and misunderstanding about treatment efficacy and disease progression.
Bias read (Center): The article presents a balanced view of the issue, focusing on the medical and public health challenges rather than taking a partisan stance. It cites expert opinions and official data without overtly favoring any political ideology. The emphasis is on the systemic barriers to treatment access and诊断
